In this training, Dr. Jorge Mera discusses the epidemiology of HCV, how to recognize clinical manifestations, ways to implement screening & interpret diagnostic tests, and how to develop treatment &… […]
Keyword: direct acting antiviral
HCV 101: Screening, Treatment and Management | January 29, 2025
In this training, Dr. Jorge Mera discusses screening, treatment and management of patients with hepatitis C in primary care and provides an opportunity to become part of a learning community. […]
Read More… from HCV 101: Screening, Treatment and Management | January 29, 2025
HCV Direct Acting Antiviral Treatment Interruptions | February 5, 2025
In this presentation, Dr. Paulina Deming, PharmD, PhC, RPh, discusses how to apply the guidance provided by the Infectious Diseases Society of America (IDSA) and the American Association for the… […]
Read More… from HCV Direct Acting Antiviral Treatment Interruptions | February 5, 2025
A National Initiative to Eliminate HCV in the United States | March 20, 2024
In this presentation Dr. Karla Thornton provides an update on the national initiative to eliminate HCV in the United States, including a background on the epidemiology of the the public… […]
Read More… from A National Initiative to Eliminate HCV in the United States | March 20, 2024
A National Initiative to Eliminate HCV in the United States | June 21, 2023
In this presentation Dr. Karla Thornton provides an update on the national initiative to eliminate HCV in the United States, including a background on the epidemiology of the the public… […]
Read More… from A National Initiative to Eliminate HCV in the United States | June 21, 2023
Hepatitis C Direct Acting Antiviral Treatment Interruptions | June 7, 2023
In this presentation Dr. Karla Thornton discusses how to apply the guidance provided by the AASLD/IDSA on HCV DAA treatment interruptions, identify when patients should have DAA therapy continued vs… […]
Read More… from Hepatitis C Direct Acting Antiviral Treatment Interruptions | June 7, 2023
The Impact of SVR on Cirrhosis and Non-Liver Complications | December 11, 2018
Annette Hewitt and Lisa Townshend-Bulson, Family Nurse Practitioners from the Alaska Native Tribal Health Consortium, Liver Disease & Hepatitis Program, present on the impact of sustained virologic response (SVR) on… […]
Read More… from The Impact of SVR on Cirrhosis and Non-Liver Complications | December 11, 2018











































